Basic Information
Basic information for LINC02235-212-36aa
Peptide Name LINC02235-212-36aa
Genome Position chr8:81923074-81923181[+]
Species Human
Peptide Sequence MTVILGHPSVGIWESLQLFISSLLLCVFHPEVYKVK
Peptide Length 36
Unique No (LINC02235-201-36aa,LINC02235-202-36aa,LINC02235-203-36aa,LINC02235-204-36aa,LINC02235-205-36aa,LINC02235-206-36aa,LINC02235-208-36aa,LINC02235-209-36aa,LINC02235-210-36aa,LINC02235-211-36aa,LINC02235-213-36aa)
Grand Average of Hydropathicity 0.9028
Relative Molecular Mass 4715.47
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000254689;LINC02235
Transcript ID/Name ENST00000670794;LINC02235-212
Transcript Length 1823
Coding Ability 0.3012
DNA Sequence Corresponding to Peptide ATGACTGTCATCCTGGGACATCCTTCTGTTGGAATCTGGGAGAGCTTACAACTTTTCATATCCTCTCTTCTTCTTTGTGTTTTTCACCCTGAAGTGTACAAAGTCAAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :